News & Updates

Cytisine on par with nortriptyline for smoking cessation
Cytisine on par with nortriptyline for smoking cessation
30 Sep 2024

Treatment with cytisine shows comparable efficacy to that of nortriptyline for smoking cessation at 1 year, according to a study. In addition, adverse events for both medications are few and well-tolerated.

Cytisine on par with nortriptyline for smoking cessation
30 Sep 2024
Benralizumab offers sustained remission in severe eosinophilic asthma
Benralizumab offers sustained remission in severe eosinophilic asthma
30 Sep 2024
Autism risk in children not heightened by COVID-19 pandemic exposure
Autism risk in children not heightened by COVID-19 pandemic exposure
29 Sep 2024 byJairia Dela Cruz

Children born during the COVID-19 pandemic or to mothers with history of prenatal SARS-CoV-2 infection are not at increased risk of autism compared with their counterparts who were born before the pandemic or have no exposure to maternal SARS-CoV-2 infection, as reported in a cohort study.

Autism risk in children not heightened by COVID-19 pandemic exposure
29 Sep 2024
Long-term bulevirtide use safe, efficacious in chronic HDV
Long-term bulevirtide use safe, efficacious in chronic HDV
29 Sep 2024 byStephen Padilla

Longer treatment with bulevirtide (BLV) monotherapy in patients with chronic hepatitis delta (CHD) for 96 weeks results in sustained or continued improvements in virologic, biochemical, and combined responses, a study has shown.

Long-term bulevirtide use safe, efficacious in chronic HDV
29 Sep 2024